Ew Healthcare Partners Fund 2, L.P. - May 18, 2021 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Other*
Signature: EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter
Stock symbol: TELA
Transactions as of: May 18, 2021
Transactions value $: $166,592
Form type: 4
Date filed: 5/20/2021, 07:01 PM
Previous filing: May 18, 2021
Next filing: May 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$47.2K	+3.55K	+0.21%	$13.30	1.68M	May 18, 2021	See Footnotes	F1, F2
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$6.05K	+450	+0.03%	$13.44	1.68M	May 19, 2021	See Footnotes	F1, F2
transaction	TELA	Common Stock, par value $0.001 per share	Purchase	$113K	+8.53K	+0.51%	$13.30	1.69M	May 20, 2021	See Footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,393 shares, 177 shares, and 3,350 shares and Fund 2-A purchased 2,153 shares, 273 shares, and 5,175 shares of the amounts shown purchased on each of 5/18/2021, 5/19/2021 and 5/20/2021, respectively. Fund 2 now holds a total of 688,404 shares of the Issuer and Fund 2-A now holds a total of 1,002,830 shares of the Issuer.
F2	EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Content

Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,393 shares, 177 shares, and 3,350 shares and Fund 2-A purchased 2,153 shares, 273 shares, and 5,175 shares of the amounts shown purchased on each of 5/18/2021, 5/19/2021 and 5/20/2021, respectively. Fund 2 now holds a total of 688,404 shares of the Issuer and Fund 2-A now holds a total of 1,002,830 shares of the Issuer.

EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.